Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBX domain protein 11 (UBXN11) is a member of the UBX domain-containing protein family, functioning as a cytoskeletal organizer and scaffold for signal transduction. It interacts with Rnd subfamily Rho GTPases and heterotrimeric G proteins, promoting activation of RhoA and modulating actin cytoskeleton dynamics. UBXN11 also activates the NF-κB pathway, contributing to colorectal cancer cell proliferation and tumor progression. This protein is emerging as a prognostic biomarker and potential immunomodulatory agent in colorectal cancer, with possible roles as a tumor antigen (COA-1). While the therapeutic targetability of UBXN11 is under investigation, its broad involvement in cytoskeletal regulation, signaling, and cancer biology suggests significant translational interest
Mechanistic action for drugs targeting UBXN11 is not yet characterized; implied future relevance for inhibition/modulation in cancer, especially via NF-κB pathway regulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UBX domain protein 11 (UBXN11).